0

Invivyd to Host Conference Call to Announce Results from Interim Analysis of Phase 3 DECLARATION Clinical Trial on November 23, 2026

Investor call to be held at 8:30 a.m. ETNEW HAVEN, Conn., Nov. 22, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will host an investor call to announce results from an interim analysis of the ongoing Phase 3 DECLARATION clinical trial on Monday, November 23, 2026 at ...